Clinical Trials Browser

Phase 1/2 × Advanced Non-Small Cell Lung Cancer × Drug Therapy × Clear all

NCT05978401 2023-08-07

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Advanced Non-Small Cell Lung Cancer